← Home / ACHIEVE LIFE SCIENCES, INC. (ACHV)
Stock Analysis

ACHIEVE LIFE SCIENCES, INC. (ACHV)

ACHV
ACHV · Healthcare • Biotechnology
8.29 -2.18%
Track ACHV in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when ACHV price is:
52W Range Position
96%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-09-03 21:44 UTC
WOI Investment Thesis
Constructive
Watch confirmation and structural levels before acting.
⚖️
Fundamentals
Negative / Mixed / Strong
Price Structure
Constructive
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
No reliable structural support level is currently available.
Not available
Break Above
No setup-specific trigger is available; nearest structural resistance is shown.
8.61
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
14
Equity Offering / Capital Raise
HIGH
ACHV equity financing update
On August 14, 2026, Achieve Life Sciences, Inc.
8-K Filing SEC EDGAR
AUG
11
Financial Results
HIGH
ACHV reports financial results
(Exact name of Registrant as Specified in Its Charter) Delaware 033-80623 95-4343413 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 22722 29th Drive SE , Suite 100 Bothell , WA 98021 1040 West Georgia , Suite 1030 Vancouver , BC , Canada V6E 4H1 (Address of...
8-K Filing SEC EDGAR
JUL
6
Shareholder Vote
MEDIUM
ACHV shareholder vote update
The following is a brief description of each matter voted upon at the Annual Meeting and the certified voting results.
8-K Filing SEC EDGAR
What's Driving ACHV?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Profitability is negative. Cash generation is mixed. Balance-sheet quality is strong.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
No qualified technical setup is currently active.
RSI(14)
64.8
Price Chart
ACHV — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-09-02
Fair
Fair valuation
Valuation looks broadly balanced relative to current fundamentals.
Market Cap
$848.9M
Company size
EV
$676.6M
Debt-adjusted value
EV/EBIT
81.6
Very high
P/FCF
5.4
Low multiple
FCF Yield
18.41%
Cash return
Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Mixed
Profitability
Negative
Cash Flow
Mixed
Balance Sheet
Strong
📈 Net Income
-74.77M
↘ Negative
🧮 EPS (Basic)
-0.80
↘ Negative
ACHIEVE LIFE SCIENCES, INC.
Healthcare • Biotechnology